Blencowe Resources: Aspiring to become one of the largest graphite producers in the world. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCap-xx Regulatory News (CPX)

Share Price Information for Cap-xx (CPX)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 0.0825
Bid: 0.08
Ask: 0.085
Change: 0.005 (6.45%)
Spread: 0.005 (6.25%)
Open: 0.0775
High: 0.0825
Low: 0.0775
Prev. Close: 0.0775
CPX Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Directorate Change

9 May 2007 07:02

CAP-XX Limited09 May 2007 CAP-XX Appoints Brett Sandercock as Non-Executive Director Sydney, Australia - May 9, 2007 - CAP-XX Limited, a world leader in the designand manufacture of thin-form supercapacitors and energy management systems,today announces that it has appointed Bret Sandercock as a Non-ExecutiveDirector and Chairman of the audit committee. Brett Sandercock is Chief Financial Officer of ResMed (NYSE: RMD and ASX:RMD.AX), a US medtech company recognised by Forbes as one of the Best SmallCompanies in the US for the 10th year in a row. Prior to joining ResMEd in 1998he worked as Manager, Financial Accounting and Group Reporting at NortonAbrasives, a division of the French multi-national, Saint Gobain. Anthony Kongats, CEO of CAP-XX, said: "Brett is an excellent addition to our non-executive team. At ResMed he has beenpart of the team that has stewarded the company through a period of tremendousgrowth. His expertise and counsel will be a valuable asset to the Company as wecontinue to make good progress in advancing our discussions with the world'sleading mobile hand set manufacturers." For further information contact: CAP-XXAnthony Kongats, Chief Executive Officer +61 (0) 2 9428 0139 Gavin Anderson & Company (Financial PR)Robert Speed / Deborah Walter +44 (0) 20 7554 1400 Collins Stewart (Nomad)Tim Mickley +44 (0) 20 7523 8000 Notes to Editors: CAP-XX is a world leader in the design and manufacture of thin formsupercapacitors and energy management systems, predominantly for portableelectronic devices. The unique feature of CAP-XX's supercapacitors is their ability to store highvolumes of energy and output high power levels within a thin form design. Theseattributes will be critical for the next generation of high volume, power-hungryportable electronic devices, including mobile phones. Portable devices are one of the fastest growing segments of the electronicsmarket and provide the greatest opportunities for CAP-XX's products. CAP-XX'sproducts are already an established enabling technology for the currentgeneration of wireless devices, such as PDAs and PCMCIA cards. More information is available at www.cap-xx.com This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
7th May 202410:10 amRNSHolding(s) in Company
7th May 20247:00 amRNSTrading Update
1st May 202411:08 amRNSHolding(s) in Company
30th Apr 20245:00 pmRNSTotal Voting Rights
25th Apr 20249:24 amRNSHolding(s) in Company
24th Apr 20245:04 pmRNSN05/24 - CAP-XX Limited - Restoration of trading
23rd Apr 20248:36 amRNSResult of General Meeting
8th Apr 20249:12 amRNSLitigation with Kyocera AVX settled
28th Mar 20245:00 pmRNSTotal Voting Rights
27th Mar 20248:22 amRNSSuspension of trading
27th Mar 20247:29 amRNSN04/24 - CAP-XX Limited - Suspension of trading
25th Mar 20247:00 amRNSResult of Retail Offer and Total Voting Rights
22nd Mar 20247:00 amRNSResult of Placing and Notice of General Meeting
21st Mar 20244:40 pmRNSREX Retail Offer
21st Mar 20244:35 pmRNSProposed Placing and Subscription to raise £2.0m
21st Mar 20249:00 amRNSLitigation Settlement Agreement with Tesla, Inc
19th Mar 202412:31 pmRNSHolding(s) in Company
18th Mar 20242:56 pmRNSHolding(s) in Company
15th Mar 202412:50 pmRNSHolding(s) in Company
15th Mar 20247:07 amRNSHolding(s) in Company
14th Mar 20247:00 amRNSUpdate on litigation
13th Mar 20247:00 amRNSCorporate Update
12th Mar 20247:00 amRNSRetirement of CFO
28th Feb 20247:00 amRNSUpdate on litigation and trading
19th Feb 20247:00 amRNSCessation of appeals process
1st Feb 20247:00 amRNSInterim Results
29th Jan 20247:00 amRNSUpdate on Patent Infringement
22nd Jan 202412:57 pmRNSChange of Joint Broker
10th Jan 20247:02 amRNSUpdate on IP and appeals process
29th Dec 20231:00 pmRNSTotal Voting Rights
21st Dec 20237:00 amRNSTrading Update
18th Dec 20237:00 amRNSUpdate on Patent Infringement
7th Dec 20237:00 amRNSCAP-XX finalises two new patents
5th Dec 20237:00 amRNSIssue of Shares and Director/PDMR Shareholdings
1st Dec 20237:00 amRNSUpdate re. R&D rebate and other matters
29th Nov 20237:00 amRNSHolding(s) in Company
22nd Nov 202311:29 amRNSHolding(s) in Company
3rd Nov 20239:05 amRNSResult of AGM and Directorate Change
3rd Nov 20237:05 amRNSAGM Trading Update
26th Oct 20232:05 pmRNSHolding(s) in Company
13th Oct 20239:45 amRNSNotice of AGM
4th Oct 20237:00 amRNSExpansion of sales operations
29th Sep 20237:00 amRNSAudited results for the year ended 30 June 2023
14th Sep 202312:29 pmRNSHolding(s) in Company
2nd Aug 20237:00 amRNSPre-close Trading Update and Notice of Results
31st Jul 20239:53 amRNSHolding(s) in Company
18th Jul 202310:27 amRNSUpdate on Patent Infringement
30th Jun 20235:00 pmRNSTotal Voting Rights
13th Jun 20237:00 amRNSHolding(s) in Company
9th Jun 20237:53 amRNSAppointment of Chief Executive Officer

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.